L26/P-686 Associations of FSHR rs6165 and rs6166 polymorphisms with ovarian response and IVF outcomes in POSEIDON group 3–4 patients undergoing mild stimulation
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von T.T. Hoang Thi und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Are FSHR rs6165 and rs6166 polymorphisms associated with ovarian response parameters and clinical outcomes in POSEIDON group 3–4 patients undergoing mild ovarian stimulation IVF? Summary answer FSHR rs6165 was associated with ovarian response, while rs6166 showed a recessive genotype–specific effect; neither variant significantly influenced pregnancy outcomes. What is known already POSEIDON group 3–4 patients represent a poor-prognosis IVF population characterized by diminished ovarian reserve and substantial variability in ovarian response. Mild ovarian stimulation protocols are increasingly applied in this group; however, predicting individual gonadotropin sensitivity remains challenging. Functional polymorphisms of the follicle-stimulating hormone receptor (FSHR), particularly rs6165 (Ala307Thr) and rs6166 (Asn680Ser), have been linked to ovarian response in IVF, but existing evidence is inconsistent and largely derived from normoresponder or unselected populations. Data focusing specifically on poor-prognosis patients undergoing mild stimulation are limited. Study design, size, duration This prospective observational cohort study included 101 women classified as POSEIDON groups 3 and 4. All participants underwent IVF using mild ovarian stimulation protocols and were followed from stimulation initiation through pregnancy outcome assessment within a single treatment cycle. Participants/materials, setting, methods Women meeting POSEIDON group 3–4 criteria and undergoing IVF at a tertiary fertility center were enrolled. Participants were genotyped for FSHR rs6165 and rs6166 polymorphisms. Primary outcomes included ovarian response parameters—FOI, FORT, and the number of retrieved and mature (MII) oocytes—while secondary outcomes comprised fertilization, embryo development, and clinical and ongoing pregnancy rates. Main results and the role of chance Baseline characteristics, including age, BMI, AMH, AFC, and basal gonadotropin levels, were comparable across FSHR rs6165 and rs6166 genotypes. For rs6165, women with the AA genotype exhibited a significantly stronger ovarian response than those with AG and GG genotypes, with a higher number of retrieved oocytes (5.33 ± 3.02 vs 4.73 ± 2.78 and 3.78 ± 2.11), more MII oocytes, and a higher FOI (81.21 ± 49.89 vs 73.36 ± 45.90 and 58.19 ± 33.94; p < 0.05). For rs6166, a significant association emerged only under the recessive model, whereby GG genotype carriers had a shorter stimulation duration and a lower total oocyte yield than AA/AG carriers (p = 0.01 and p = 0.03). No significant differences were observed in FOI, embryo development, fertilization, or pregnancy outcomes. Clinical and ongoing pregnancy rates did not differ significantly across genotypes for either variant, although consistently lower rates were observed among GG carriers. A strong linkage disequilibrium between rs6165 and rs6166 was identified (p < 0.0001). Limitations, reasons for caution This single-center study with a relatively limited sample size may have reduced power to detect differences in clinical pregnancy outcomes. The findings should therefore be interpreted cautiously and confirmed in larger, multi-center studies Wider implications of the findings FSHR polymorphisms, particularly rs6165, may help explain inter-individual variability in ovarian responsiveness among poor-prognosis IVF patients. Incorporating genetic information could support individualized counselling and stimulation planning, although its value for predicting pregnancy outcomes appears limited. Trial registration number No
Zitieren
APA
Thi, T. H., The, S. T., Ngoc, N. N., Nguyet, M. H., Dinh, M. P., Thi, N. H., Tien, S. T., & Sy, H. H. (2026). L26/P-686 Associations of FSHR rs6165 and rs6166 polymorphisms with ovarian response and IVF outcomes in POSEIDON group 3–4 patients undergoing mild stimulation. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1016
Vancouver
Thi TH, The ST, Ngoc NN, Nguyet MH, Dinh MP, Thi NH, et al. L26/P-686 Associations of FSHR rs6165 and rs6166 polymorphisms with ovarian response and IVF outcomes in POSEIDON group 3–4 patients undergoing mild stimulation. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1016
BibTeX
@article{Thi2026,
author = {Thi, T.T. Hoang and The, S. Trinh and Ngoc, N. Nguyen and Nguyet, M. Ho and Dinh, M. Pham and Thi, N. Hoang and Tien, S. Trieu and Sy, H. Ho},
title = {L26/P-686 Associations of FSHR rs6165 and rs6166 polymorphisms with ovarian response and IVF outcomes in POSEIDON group 3–4 patients undergoing mild stimulation},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1016}
}
EUVIMED